van der Hoorn JW - Search Results

1

Remote ischaemic preconditioning by brief hind limb ischaemia protects against renal ischaemia-reperfusion injury: the role of adenosine.

Wever KE, Warlé MC, Wagener FA, van der Hoorn JW, Masereeuw R, van der Vliet JA, Rongen GA. Wever KE, et al. Among authors: van der hoorn jw, van der vliet ja. Nephrol Dial Transplant. 2011 Oct;26(10):3108-17. doi: 10.1093/ndt/gfr103. Epub 2011 Mar 21. Nephrol Dial Transplant. 2011. PMID: 21427077

2

P-glycoprotein-deficient mice have proximal tubule dysfunction but are protected against ischemic renal injury.

Huls M, Kramers C, Levtchenko EN, Wilmer MJ, Dijkman HB, Kluijtmans LA, van der Hoorn JW, Russel FG, Masereeuw R. Huls M, et al. Among authors: van der hoorn jw. Kidney Int. 2007 Nov;72(10):1233-41. doi: 10.1038/sj.ki.5002522. Epub 2007 Sep 12. Kidney Int. 2007. PMID: 17851469 Free article.

3

Negative effects of rofecoxib treatment on cardiac function after ischemia-reperfusion injury in APOE3Leiden mice are prevented by combined treatment with thromboxane prostanoid-receptor antagonist S18886 (terutroban).

van der Hoorn JW, Jukema JW, Bekkers ME, Princen HM, Corda S, Emeis JJ, Steendijk P. van der Hoorn JW, et al. Crit Care Med. 2008 Sep;36(9):2576-82. doi: 10.1097/CCM.0b013e318183f0fd. Crit Care Med. 2008. PMID: 18679128

4

Olmesartan and pravastatin additively reduce development of atherosclerosis in APOE*3Leiden transgenic mice.

van der Hoorn JW, Kleemann R, Havekes LM, Kooistra T, Princen HM, Jukema JW. van der Hoorn JW, et al. J Hypertens. 2007 Dec;25(12):2454-62. doi: 10.1097/HJH.0b013e3282ef79f7. J Hypertens. 2007. PMID: 17984667

5

Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increase.

Simic B, Mocharla P, Crucet M, Osto E, Kratzer A, Stivala S, Kühnast S, Speer T, Doycheva P, Princen HM, van der Hoorn JW, Jukema JW, Giral H, Tailleux A, Landmesser U, Staels B, Lüscher TF. Simic B, et al. Among authors: van der hoorn jw. Atherosclerosis. 2017 Feb;257:186-194. doi: 10.1016/j.atherosclerosis.2017.01.011. Epub 2017 Jan 16. Atherosclerosis. 2017. PMID: 28152406

6

Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy.

Jukema JW, van der Hoorn JW. Jukema JW, et al. Among authors: van der hoorn jw. Expert Opin Pharmacother. 2004 Feb;5(2):459-68. doi: 10.1517/14656566.5.2.459. Expert Opin Pharmacother. 2004. PMID: 14996641 Review.

7

Torcetrapib does not reduce atherosclerosis beyond atorvastatin and induces more proinflammatory lesions than atorvastatin.

de Haan W, de Vries-van der Weij J, van der Hoorn JW, Gautier T, van der Hoogt CC, Westerterp M, Romijn JA, Jukema JW, Havekes LM, Princen HM, Rensen PC. de Haan W, et al. Among authors: van der hoogt cc, van der hoorn jw. Circulation. 2008 May 13;117(19):2515-22. doi: 10.1161/CIRCULATIONAHA.107.761965. Epub 2008 May 5. Circulation. 2008. PMID: 18458167

8

Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.

van der Hoorn JW, de Haan W, Berbée JF, Havekes LM, Jukema JW, Rensen PC, Princen HM. van der Hoorn JW, et al. Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):2016-22. doi: 10.1161/ATVBAHA.108.171363. Epub 2008 Jul 31. Arterioscler Thromb Vasc Biol. 2008. PMID: 18669886

9

Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin.

Kühnast S, van der Hoorn JW, van den Hoek AM, Havekes LM, Liau G, Jukema JW, Princen HM. Kühnast S, et al. Among authors: van den hoek am, van der hoorn jw. J Hypertens. 2012 Jan;30(1):107-16. doi: 10.1097/HJH.0b013e32834ddd8e. J Hypertens. 2012. PMID: 22134386

10

Gender-dependent effects of high-fat lard diet on cardiac function in C57Bl/6J mice.

Louwe MC, van der Hoorn JW, van den Berg SA, Jukema JW, Romijn JA, van Dijk KW, Rensen PC, Smit JW, Steendijk P. Louwe MC, et al. Among authors: van dijk kw, van der hoorn jw, van den berg sa. Appl Physiol Nutr Metab. 2012 Apr;37(2):214-24. doi: 10.1139/h11-153. Epub 2012 Mar 1. Appl Physiol Nutr Metab. 2012. PMID: 22380727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page